Steven J. Mento

2014

In 2014, Steven J. Mento earned a total compensation of $3.7M as President and Chief Executive Officer at Conatus Pharmaceuticals, a 467% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$115,000
Option Awards$3,083,560
Salary$460,000
Other$15,850
Total$3,674,410

Mento received $3.1M in option awards, accounting for 84% of the total pay in 2014.

Mento also received $115K in non-equity incentive plan, $460K in salary and $15.9K in other compensation.

Rankings

In 2014, Steven J. Mento's compensation ranked 2,373rd out of 13,032 executives tracked by ExecPay. In other words, Mento earned more than 81.8% of executives.

ClassificationRankingPercentile
All
2,373
out of 13,032
82nd
Division
Manufacturing
848
out of 4,966
83rd
Major group
Chemicals And Allied Products
261
out of 1,686
85th
Industry group
Drugs
202
out of 1,365
85th
Industry
Pharmaceutical Preparations
166
out of 1,043
84th
Source: SEC filing on April 28, 2016.

Mento's colleagues

We found two more compensation records of executives who worked with Steven J. Mento at Conatus Pharmaceuticals in 2014.

2014

David Hagerty

Conatus Pharmaceuticals

Executive Vice President, Clinical Development

2014

Alfred Spada

Conatus Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like